Clinical trial
A Pragmatic Randomized Phase II Trial Evaluating Total Ablative Therapy for Patients With Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
NCT05673148 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pragmatic Randomized Phase II Trial Evaluating Total Ablative Therapy for Patients With Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- October 9, 2023
- Completion date
- August 12, 2032
- Enrollment
- 146 (estimated)
- Sites
- 189
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic colorectal adenocarcinoma, oligometastatic colorectal carcinoma, stage iv colorectal cancer ajcc v8